Skip to main content
Premium Trial:

Request an Annual Quote

BioDiscovery Wins SBIR Grant for Cancer Genome Atlas Platform, Partners with Huntsman

NEW YORK (GenomeWeb) – Genomic analysis software maker BioDiscovery said today it will use a $157,000 grant from the National Cancer Institute to analyze and improve copy number variant data from The Cancer Genome Atlas program.

The Small Business Innovation Research grant will fund efforts to develop and commercialize CNV and sequence variant data that researchers will use in studies of tumorigenesis and disease progression, and which will provide a validation set for use in international studies.

The Hawthorne, Calif.-based company said the Huntsman Cancer Institute (NCI) and the University of Utah will help it develop and validate the cancer data offering that it aims take to market.

BioDiscovery offers tools for analyzing and visualizing data from next-generation sequencing and microarray platforms, including its flagship Nexus Copy Number software.

"We are applying methods, algorithms, and best practices learned from our experiences in clinical pathology settings to TCGA data," Soheil Shams, BioDiscovery's Chief Scientific Officer, said in a statement. "It's a painstaking process, but the result will be the highest-fidelity CNV data from TCGA, and will integrate with our analysis platform to let researchers quickly access and interrogate this database."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.